Herbal kava: reports of liver toxicity

Wooltorton, Eric
March 2002
CMAJ: Canadian Medical Association Journal;3/19/2002, Vol. 166 Issue 6, p777
Academic Journal
journal article
Advises that products containing kava, such as those used to induce relaxation, treat anxiety, or induce sleep, should not be used, according to Health Canada. Derivation of kava lactones from the dried root of Piper methysticum; Way that physicians have been asked to review cases of patients with liver toxicity and report adverse events which may be related to the use of kava to Health Canada.


Related Articles

  • Kava: a safe soother. Cohen, Sharon // Shape;Jan2001, Vol. 20 Issue 5, p33 

    Reports on the finding that doses of kava for up to 300 milligrams a day are effective and safe for treating anxiety.

  • Are Kavalactones the Hepatotoxic Principle of Kava Extracts? The Pitfalls of the Glutathione Theory. Schmidt, Mathias // Journal of Alternative & Complementary Medicine;Apr2003, Vol. 9 Issue 2, p183 

    Comments on a study on the hepatotoxicity of kava extracts. Background of toxicologic studies with kava extract and isolated kavalactones; Details on kavalactone-free preparations; Information on the acute toxicity of kavalactones in animal experiments.

  • In Ironic Twist, Kava Causes Anxiety Over Link to Liver Problems.  // Environmental Nutrition;Jan2002, Vol. 25 Issue 1, p3 

    Examines the effects of kava on anxiety and liver problems in the United States. Dosage and prescription; Knowledge of the safety measure; Indications and contraindications.

  • Kava--An Ancient Remedy for a Modern Problem. Brown, Edwin W. // Medical Update;Mar99, Vol. 22 Issue 9, p3 

    Focuses on kava, an alternative drug to antianxiety medications. Origin of the drug; Standard concentrations of the drug sold in drug stores and health-food shops.

  • Mellow Out With Kava. Antonio, Jose // Joe Weider's Muscle & Fitness;Dec98, Vol. 59 Issue 12, p162 

    Provides information on kava, a herbal plant from the South Pacific Islands, which may be an alternative to medicines used to treat anxiety disorders. Results of an experiment on the effects of a kava-kava extract identified as WS 1490; Side effects of kava; Necessary precautions regarding the...

  • Warning against unauthorised ephedrine and kava kava products.  // Reactions Weekly;8/30/2008, Issue 1217, p2 

    The article reports on the warning issued by Health Canada against the unauthorised natural health products Life Choice ephedrine hydrochloride 30-milligram (mg) capsules and Life Choice kava kava 150mg capsules. The agency said that Life Choice ephedrine contains an excessive amount of...

  • Response to Schmidt "Are Kavalactones the Hepatotoxic Principle of Kava Extracts? The Pitfalls of the Glutathione Theory" Whitton, Peter A. // Journal of Alternative & Complementary Medicine;Apr2003, Vol. 9 Issue 2, p187 

    Presents a reply to comments regarding a study on the hepatotoxicity of kava. Mechanism of action of kava; Effect of kava on human cytochrome p450 enzymes; Information on the toxicity of kavalactones.

  • Kava: a test case for Canada's new approach to natural health products. Boon, Heather S.; Wong, Albert H.C. // CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1163 

    Comments on the use of the herbal kava for treating anxiety. Recommended dose of kava extract; Criticisms of the evidence for kava hepatotoxicity; Significance of the 2002 decision of Health Canada to reclassify kava as a conventional drug.

  • Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Malsch, U.; Kieser, M. // Psychopharmacology;2001, Vol. 157 Issue 3, p277 

    A 5-week randomized, placebo-controlled, double-blind study was carried out to investigate the efficacy of kava-kava special extract WS[sup ®] 1490 in non-psychotic nervous anxiety, tension and restlessness states. During the first treatment week, the study dose drug was increased from 50 mg...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics